Drugs / TacroBell SR cap.
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT03749356 | Sep 2018 → Jul 2020 | — | Chong Kun Dang Pharmaceutical | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TacroBell SR cap. | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03749356 ↗ |
| Known as | Tacrolimus SR cap. | “Tacrolimus SR cap.” NCT03749356 ↗ |
| Route | Oral | “Orally, once-daily in the morning” NCT03749356 ↗ |